Dendreon

Why Docs Are Skittish About Prescribing Provenge
Pharmalot
Tue, 08/30/11 - 11:37 am
Provenge
physicians
prostate cancer
Dendreon
Dendreon's Golden Age Is Still On Track
Seeking Alpha
Mon, 08/29/11 - 01:43 pm
Dendreon
Provenge
prostate cancer
Dendreon: The Challenge Of Misinformation
Seeking Alpha
Mon, 08/29/11 - 11:00 am
Dendreon
Provenge
prostate cancer
6 Healthcare Stocks Primed For A Rebound
Seeking Alpha
Fri, 08/26/11 - 09:16 am
Apricus Biosciences
CytRx
Geron
Dendreon
SIGA technologies
ImmunoCellular
Payers expect Provenge sales to stay flat
Fierce Pharma
Thu, 08/25/11 - 11:49 am
Dendreon
Provenge
prostate cancer
Seattle Genetics Faces Hurdles as Investors Dread Dendreon-Like Rollout
Bloomberg
Mon, 08/22/11 - 06:13 pm
Seattle Genetics
Dendreon
Provenge
Adcetris
lymphoma
How Undervalued Dendreon Is
Seeking Alpha
Fri, 08/19/11 - 11:16 am
Dendreon
Provenge
prostate cancer
3 biotech stocks battle the ‘Dendreon Effect’ - Company’s troubles with Provenge chill fellow drug makers
Marketwatch
Fri, 08/19/11 - 09:20 am
Dendreon
Provenge
Savient
Human Genome Sciences
Vertex Pharmaceuticals
InterMune
Seattle Genetics
Navigating Cancer Vaccines' High-Risk/High-Reward Field
Seeking Alpha
Wed, 08/17/11 - 12:09 pm
cancer
vaccines
Dendreon
Provenge
ICT-107
ImmunoCellular
Amgen
Take a Chance on Dendreon Corp
Seeking Alpha
Tue, 08/16/11 - 10:05 am
Dendreon
Provenge
prostate cancer
Dendreon and Provenge: Too High of a Risk for the Reward
Seeking Alpha
Mon, 08/15/11 - 06:30 pm
prostate cancer
Dendreon
Provenge
JNJ
When to Buy Biotechnology Stocks?
Seeking Alpha
Mon, 08/15/11 - 10:30 am
Alexion
Arena Pharmaceuticals
Dendreon
Human Genome Sciences
MannKind
Orexigen
5 Cheap Biotech Stocks That May Rebound Ahead of the Market
Seeking Alpha
Fri, 08/12/11 - 12:43 pm
BioSante
Chelsea Therapeutics
Dendreon
Keryx
Opexa
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals
Good Biotech Stocks for a Bear Market
TheStreet.com
Tue, 08/9/11 - 01:27 pm
Elan
Targacept
Dendreon
Gilead Sciences
Sequenom
Vertex Pharmaceuticals
Amgen
Alexion
Biogen Idec
Celgene
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus
Motley Fool
Mon, 08/8/11 - 09:18 am
Dendreon
biotech
Provenge
prostate cancer
Still Want to Be the Next Dendreon?
Motley Fool
Sat, 08/6/11 - 01:01 pm
Dendreon
Vertex Pharmaceuticals
Incivek
hepatitis B
Doctor Who Is a Provenge Fan Says Reimbursement Is a Risk
Seeking Alpha
Sat, 08/6/11 - 12:59 pm
Dendreon
Provenge
Levi & Korsinsky Notifies Investors With Losses on Their Investment in Dendreon Corporation of Class Action Lawsuit and the October 4, 2011 Lead Plaintiff Deadline
Yahoo/MarketWire
Sat, 08/6/11 - 12:57 pm
Dendreon
lawsuits
Do Dendreon's Problems Matter to Your Biotech Portfolio?
Seeking Alpha
Sat, 08/6/11 - 12:56 pm
Dendreon
Provenge

Pages